The NF-κB inhibitor DHMEQ decreases survival factors, overcomes the protective activity of microenvironment and synergizes with chemotherapy agents in classical Hodgkin lymphoma.
| Image |  |
|---|---|
| Description | scientific article published on 2 April 2014 |
| Author/s |
author: Antonino Carbone Kazuo Umezawa Alfonso Colombatti Donatella Aldinucci |
| Publication date | April 2, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |